SALESFORCE WKN: A0B87V ISIN: US79466L3024 Kürzel: CRM Forum: Aktien Thema: Hauptdiskussion
KEY TAKEAWAYS - Salesforce is set to report earnings for its fiscal fourth quarter of 2024 on Wednesday after the closing bell. - Analysts expect the company will swing to a profit with net income of $1.26 billion after posting a loss in the year-ago period due to restructuring costs. - Revenue is expected to climb 10% from a year earlier to a record $9.2 billion. - Investors may watch Salesforce's data cloud revenue to gauge customer interest in the company's efforts to expand its artificial intelligence offerings across different products and services. Salesforce (CRM) is expected to swing back to profitability after posting a loss in the year-ago period when it reports fourth-quarter fiscal 2024 results after the closing bell Wednesday, with gains driven by growth across business lines and the company's data cloud operations in particular, as it works to expand artificial intelligence offerings across different products and services.
|
|
Thema | ||
|---|---|---|---|
| 1 | PLUG POWER Hauptdiskussion | -6,38 % | |
| 2 | DAX Hauptdiskussion | +0,63 % | |
| 3 | Das neue Dax Prognose Forum | +0,63 % | |
| 4 | AIXTRON Hauptdiskussion | -1,20 % | |
| 5 | NEL ASA Hauptdiskussion | -1,54 % | |
| 6 | AFC ENERGY Hauptdiskussion | +0,74 % | |
| 7 | BIOXCEL THERAPEUT DL-,001 Hauptdiskussion | +7,41 % | |
| 8 | TESLA MOTORS Hauptdiskussion | -0,28 % | |
| 9 | Dax Prognose | +0,63 % | |
| 10 | Plug Power ohne Spam | -6,38 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | PLUG POWER Hauptdiskussion | -6,64 % | |
| 2 | AIXTRON Hauptdiskussion | -1,24 % | |
| 3 | NEL ASA Hauptdiskussion | -1,54 % | |
| 4 | AFC ENERGY Hauptdiskussion | +0,74 % | |
| 5 | BIOXCEL THERAPEUT DL-,001 Hauptdiskussion | +7,41 % | |
| 6 | TESLA MOTORS Hauptdiskussion | -0,58 % | |
| 7 | Plug Power ohne Spam | -6,64 % | |
| 8 | Mercedes-Benz Group Hauptdiskussion | -6,49 % | |
| 9 | NIO INC.A S.ADR DL-,00025 Hauptdiskussion | +2,17 % | |
| 10 | News - InnoCan Pharma Aktie | +9,64 % | Alle Diskussionen |